Aurora Cannabis (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P) has announced product information numbers (PINs) for its medical cannabis products.

Aurora and its subsidiary CanniMed Therapeutics are adding PINs to 78 medical cannabis products to better facilitate and track insurance coverage for their Canadian patients. The products receiving PINs include dried flower, capsules, soft gels, topicals and oils.

Why PINs Are Important

PINs help employers and insurance companies classify and incorporate health care products into benefit coverage plans. Patients submitting claims to their third-party insurers can now identify specific products and thereby speed up the adjudication and medical coverage process, according to Aurora Cannabis.

MedReleaf, another wholly-owned subsidiary of Aurora, introduced PINs to 57 medical cannabis products in 2018.

“Introducing PINs for medical cannabis products will make the claims process more seamless, enabling insurance companies to add these products to their formularies while providing patients and employers with a simplified process to complete claims. It’s another step toward enhancing patient access, something Aurora cares deeply about,” Aurora CEO Terry Booth said in a statement.